JPRN-UMIN000008647已完成未知
Prospective study of TS-1 / CPT-11 plus Trastuzumab in patients with HER-2 positive metastatic breast cancer (KSCOG-BC02) - Prospective study of TS-1 / CPT-11 plus Trastuzumab in patients with HER-2 positive metastatic breast cancer (KSCOG-BC02)
Kurume University School of Medicine0 个研究点目标入组 30 人开始时间: 2012年8月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1.With contraindicate TS-1, CPT-11 and Trastuzumab 2.With active double cancer 3.With uncontrolled diabetes 4.Heart failure with clinically problem 5.Symptomatic brain metastasis 6.With mental disorder which become problem on clinical practice 7.With uncontrolled hypertension 8.Physician judged improper to entry this trial
研究者
相似试验
招募中
不适用
Additional TR study on Phase 2 study of Trastuzumab Deruxtecan in the neoadjuvant treatment for patients with HER2 positive gastric and gastroesophageal junction adenocarcinomaHER2 positive gastric and gastroesophageal junction adenocarcinomaJPRN-jRCT1030210361Shitara Kohei37
已完成
2 期
Phase II study of Trastuzuman in combination with TS-1 and Cisplatin for patients with Human Epidermal Growth Facter Receptor type-2 (HER-2)-positive Advanced Gastric CancerGastric cancerJPRN-UMIN000008389West Japan Oncology Group55
招募中
2 期
Phase II study of TS-1+CPT-11+BV followed by TS-1+L-OHP+BV in unresectable advanced colorectal cancer with RAS mutatioColorectal cancerJPRN-UMIN000014892iigata Colorectal Cancer Study Group50
招募中
不适用
Randomized phase II study of CPT-11 plus TS-1 plus Cetuximab for advanced and/or recurrent colon cancer which are oxaliplatin-resistant and KRAS wild type (OGSG 0901)advanced and/or recurrent colon cancer which are oxaliplatin-resistant and KRAS wild typeJPRN-UMIN000002695Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)35
已完成
2 期
Phase II study of TS-1 and CPT-11 combination chemotherapy in patients with advanced/recurrent colorectal cancer.advanced/recurrent colorectal cancerJPRN-UMIN000007142Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group55